The median size of HCC mass as well as different categories of BCLC staging system whether very early stage, early stage (A), intermediate stage (B), advanced stage (C), or terminal stage (D) did not differ significantly between RASSF1A methylation status (p = 0.449, p = 0.958, respectively). This evidence concerns the gene RASSF1 and hepatocellular carcinoma.